John Vong - 16 May 2023 Form 4 Insider Report for Apollo Medical Holdings, Inc. (ASTH)

Role
Chief Accounting Officer
Signature
/s/ John Vong
Issuer symbol
ASTH
Transactions as of
16 May 2023
Net transactions value
-$10,423
Form type
4
Filing time
16 Nov 2023, 16:30:34 UTC
Previous filing
13 Dec 2022
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Disposed to Issuer $0 -4,164 -52% $0.000000 3,771 16 May 2023 Direct F1
transaction AMEH Common Stock Award $0 +1,520 +40% $0.000000 5,291 16 May 2023 Direct F2
transaction AMEH Common Stock Award $0 +1,520 +29% $0.000000 6,811 16 May 2023 Direct F3
transaction AMEH Common Stock Award $0 +760 +11% $0.000000 7,571 16 May 2023 Direct F4
transaction AMEH Common Stock Award $0 +760 +10% $0.000000 8,331 16 May 2023 Direct F5
transaction AMEH Common Stock Disposed to Issuer $0 -1,520 -18% $0.000000 6,811 01 Jul 2023 Direct F2
transaction AMEH Common Stock Disposed to Issuer $0 -1,520 -22% $0.000000 5,291 01 Jul 2023 Direct F3
transaction AMEH Common Stock Tax liability $10,423 -325 -6.1% $32.07 4,966 11 Jul 2023 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents cancellation of all performance-based restricted stock awards granted on December 12, 2022.
F2 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.
F3 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. The shares of restricted stock were scheduled to vest upon achievement of a pre-established performance goal on or before July 1, 2023. The applicable performance goal was not met, and the restricted shares were forfeited.
F4 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal on or before July 1, 2023, which performance goal was met.
F5 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares of restricted stock shall vest in four equal annual installments beginning on November 30, 2023 and upon achievement of a pre-established performance goal.
F6 This transaction represents the surrender of shares to offset against tax withholding obligations associated with certain shares of the restricted stock award that vested on July 11, 2023.
F7 Includes 4,349 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 2,829 shares, of which 942 shares vest on each of July 11, 2024 and July 11, 2025 and 945 shares vest on July 11, 2026; (ii) 760 shares, which vest in four equal annual installments beginning on November 30, 2023; and (iii) 760 shares, which vest upon achievement of certain pre-established performance goals.